SDF Chatter
  • Communities
  • Create Post
  • Create Community
  • heart
    Support Lemmy
  • search
    Search
  • Login
  • Sign Up
Lugh@futurology.todayM to Futurology@futurology.todayEnglish · 19 days ago

Verve is developing a pipeline of gene editing medicines to address the drivers of atherosclerotic cardiovascular disease (ASCVD) through treatments that may only need to be given once in a lifetime.

investor.lilly.com

external-link
message-square
1
link
fedilink
  • cross-posted to:
  • futurology@futurology.today
9
external-link

Verve is developing a pipeline of gene editing medicines to address the drivers of atherosclerotic cardiovascular disease (ASCVD) through treatments that may only need to be given once in a lifetime.

investor.lilly.com

Lugh@futurology.todayM to Futurology@futurology.todayEnglish · 19 days ago
message-square
1
link
fedilink
  • cross-posted to:
  • futurology@futurology.today
alert-triangle
You must log in or register to comment.
  • Riffraffintheroom [none/use name]@hexbear.net
    link
    fedilink
    English
    arrow-up
    1    ·
    19 days ago

    That’s cool but I expect to never hear about this again ever.

Futurology@futurology.today

futurology@futurology.today

Subscribe from Remote Instance

Create a post
You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !futurology@futurology.today
Visibility: Public
globe

This community can be federated to other instances and be posted/commented in by their users.

  • 146 users / day
  • 479 users / week
  • 1.3K users / month
  • 6.1K users / 6 months
  • 25 local subscribers
  • 2.98K subscribers
  • 1.93K Posts
  • 12.1K Comments
  • Modlog
  • mods:
  • voidx@futurology.today
  • Lugh@futurology.today
  • Espiritdescali@futurology.today
  • AwesomeLowlander@futurology.today
  • BE: 0.19.11
  • Modlog
  • Instances
  • Docs
  • Code
  • join-lemmy.org